2 completed, 2 unknown, 1 recruiting. 5 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 5 | Completed 2, Unknown 2, Recruiting 1 |
| Phase 2 | 2 | Unknown 2 |
Follow Vitamin C: new trials by email Literature Review of Vitamin C trials Research Report on Vitamin C
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Combination of IV Ascorbic Acid and Adebrelimab in Metastatic Colorectal Cancer Ascorbic acid, FOLFOX Protocol, Adebrelimab - Colorectal Cancer, Vitamin C | Phase 3 | Recruiting | Fudan University | 400 | 2024-12-01 | 2024-10-24 |
| Efficacy of Megadose Vitamin C in Severe and Critical Ill COVID-19 Patients. Vitamin C, Placebo - Vitamin C, COVID-19 Pneumonia | Phase 2 / Phase 3 | Unknown | Zhujiang Hospital | 608 | 2023-01-13 | 2023-01-23 |
| Lessening Organ Dysfunction With VITamin C - COVID-19 Vitamin C, Control - Vitamin C, COVID-19 | Phase 3 | Completed | Université de Sherbrooke | 392 | 2020-08-14 | 2023-04-21 |
| Lessening Organ Dysfunction With VITamin C Vitamin C, Control - Sepsis, Vitamin C | Phase 3 | Completed | Université de Sherbrooke | 872 | 2018-11-08 | 2022-04-04 |
| Role of Vitamin C to Augment Iron Chelation With DFP or DFX Vitamin C, Defriprone, deferisarox, deferiprone , deferesarox - Vitamin c, Thalassemia Major | Phase 2 / Phase 3 | Unknown | Ain Shams University | 50 | 2014-04-01 | 2014-03-11 |
COVID-19 (3) · Coronavirus Infections (2) · Colorectal Neoplasms (1) · Sepsis (1) · beta-Thalassemia (1)
Coronaviridae Infections (3) · Infections (3) · Lung Diseases (3) · Nidovirales Infections (3) · Pneumonia (3) · Pneumonia, Viral (3) · RNA Virus Infections (3) · Respiratory Tract Diseases (3) · Respiratory Tract Infections (3) · Virus Diseases (3) · Anemia (1) · Anemia, Hemolytic (1) · Anemia, Hemolytic, Congenital (1) · Colonic Diseases (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)
Ascorbic Acid (5) · Deferiprone (1) · Folfox protocol (1) · Isoflurophate (1)
Université de Sherbrooke (2) · Ain Shams University (1) · Fudan University (1) · Zhujiang Hospital (1)
Canada (2) · China (2) · Egypt (1)
Guoxiang Cai, Doctor (1) · Liu Zhanguo, MD,PhD (1) · Neill Adhikari, MDCM FRCPC MSc (1) · Neill K Adhikari, MDCM, FRCPC, MSc (1)
PMID 31915072, PMID 34020705, PMID 35704292, PMID 37877585, PMID 39774855, PMID 40927646